中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2014年
5期
281-285
,共5页
叶敏华%张安玲%王坤%吴淼经%黄强%祝新根
葉敏華%張安玲%王坤%吳淼經%黃彊%祝新根
협민화%장안령%왕곤%오묘경%황강%축신근
miR-106b~25%miRNA表达%胶质瘤
miR-106b~25%miRNA錶達%膠質瘤
miR-106b~25%miRNA표체%효질류
miR-106b~25 cluster%miRNA expression%glioma
目的:检测胶质瘤细胞系及组织中miR-106b~25基因簇成员miR-106b、miR-93、miR-25的表达情况。方法:运用实时定量PCR的方法检测不同人脑胶质母细胞瘤细胞系及不同病理级别胶质瘤标本中miR-106b~25基因簇成员miR-106b、miR-93和miR-25的表达水平。原位杂交技术检测含不同病理级别及瘤旁正常脑组织的胶质瘤组织芯片中miR-106b~25基因簇成员的表达情况,进而分析该簇miRNAs的表达与胶质瘤病理级别的相关性。结果:以正常脑组织表达量为基准,3种miRNA在所有检测细胞系中均有增高的趋势。收集43例胶质瘤标本中,RT-PCR结果显示,随着肿瘤病理级别的升高,3种miRNA在各组中的平均表达量也逐步升高。其中,miR-106b(F=4.479,P=0.018)和miR-93(F=3.493,P=0.040)各组间的表达差异均有统计学意义。而miR-25表达无明显的统计学差异(F=2.766,P=0.075)。原位杂交结果显示3种miRNA的表达在高级别胶质瘤中的表达量明显高于低级别肿瘤。Spearman等级相关分析表明3种miRNA的表达信号强度分布均与胶质瘤的WHO病理分级呈正相关,在miR-106b、-93、-25中的相关系数分别为rs=0.617(P<0.001)、rs=0.438(P<0.001)、rs=0.463(P<0.001)。结论:miR-106b~25在胶质瘤中表达呈不同程度增高,并与肿瘤分级呈正相关。
目的:檢測膠質瘤細胞繫及組織中miR-106b~25基因簇成員miR-106b、miR-93、miR-25的錶達情況。方法:運用實時定量PCR的方法檢測不同人腦膠質母細胞瘤細胞繫及不同病理級彆膠質瘤標本中miR-106b~25基因簇成員miR-106b、miR-93和miR-25的錶達水平。原位雜交技術檢測含不同病理級彆及瘤徬正常腦組織的膠質瘤組織芯片中miR-106b~25基因簇成員的錶達情況,進而分析該簇miRNAs的錶達與膠質瘤病理級彆的相關性。結果:以正常腦組織錶達量為基準,3種miRNA在所有檢測細胞繫中均有增高的趨勢。收集43例膠質瘤標本中,RT-PCR結果顯示,隨著腫瘤病理級彆的升高,3種miRNA在各組中的平均錶達量也逐步升高。其中,miR-106b(F=4.479,P=0.018)和miR-93(F=3.493,P=0.040)各組間的錶達差異均有統計學意義。而miR-25錶達無明顯的統計學差異(F=2.766,P=0.075)。原位雜交結果顯示3種miRNA的錶達在高級彆膠質瘤中的錶達量明顯高于低級彆腫瘤。Spearman等級相關分析錶明3種miRNA的錶達信號彊度分佈均與膠質瘤的WHO病理分級呈正相關,在miR-106b、-93、-25中的相關繫數分彆為rs=0.617(P<0.001)、rs=0.438(P<0.001)、rs=0.463(P<0.001)。結論:miR-106b~25在膠質瘤中錶達呈不同程度增高,併與腫瘤分級呈正相關。
목적:검측효질류세포계급조직중miR-106b~25기인족성원miR-106b、miR-93、miR-25적표체정황。방법:운용실시정량PCR적방법검측불동인뇌효질모세포류세포계급불동병리급별효질류표본중miR-106b~25기인족성원miR-106b、miR-93화miR-25적표체수평。원위잡교기술검측함불동병리급별급류방정상뇌조직적효질류조직심편중miR-106b~25기인족성원적표체정황,진이분석해족miRNAs적표체여효질류병리급별적상관성。결과:이정상뇌조직표체량위기준,3충miRNA재소유검측세포계중균유증고적추세。수집43례효질류표본중,RT-PCR결과현시,수착종류병리급별적승고,3충miRNA재각조중적평균표체량야축보승고。기중,miR-106b(F=4.479,P=0.018)화miR-93(F=3.493,P=0.040)각조간적표체차이균유통계학의의。이miR-25표체무명현적통계학차이(F=2.766,P=0.075)。원위잡교결과현시3충miRNA적표체재고급별효질류중적표체량명현고우저급별종류。Spearman등급상관분석표명3충miRNA적표체신호강도분포균여효질류적WHO병리분급정정상관,재miR-106b、-93、-25중적상관계수분별위rs=0.617(P<0.001)、rs=0.438(P<0.001)、rs=0.463(P<0.001)。결론:miR-106b~25재효질류중표체정불동정도증고,병여종류분급정정상관。
Objective:To detect the expression of miR-106b~25 cluster in glioma cell line and tissues. Methods:Real-time PCR was performed to determine the expression of miR-106b~25 cluster members (miR-106b, miR-93, and miR-25) in different human glio-blastoma cell lines. Different pathological grade glioma specimens were surgically removed. In-situ hybridization was performed to de-tect the expression of miR-106b~25 cluster members in different pathological levels of glioma tissues. Results:In the expression of the benchmark on normal brain tissues, three kinds of miRNAs in all test cell lines have a tendency to increase. Based on the expression of the pathological level I average rate in 43 cases of glioma specimens collected after neurosurgical operations, the real-time PCR results showed that the average expression quantity of the three kinds of miRNAs in each group gradually increase. The increase in tumor path-ological levels results in statistically significant expression differences of miR-106b and miR-93 between the groups (F=4.479, P=0.018 and F=3.493, P=0.040, respectively). However, miR-25 expression differences between the groups have no statistically signifi-cant differences (F=2.766, P=0.075). In situ hybridization results show that the expressions of three miRNAs in high grade gliomas are significantly higher than that in the low-level tumor. Spearman rank correlation analysis results indicate that the expression of these miRNAs signal-intensity distribution is positively correlated with glioma, in accordance with WHO pathology classification. The corre-lation coefficient for miR-106b, miR-93, and miR-25 are 0.617, 0.438, and 0.463, respectively (P<0.001). Conclusion:The expression of miR-106b~25 cluster members is up-regulated in the glioma and is positively correlated with tumor grade.